SE8901342L - Biologiska material, foerfaranden foer framstaellning av biologiska material samt foer anvaendning av saadana material i terapi - Google Patents
Biologiska material, foerfaranden foer framstaellning av biologiska material samt foer anvaendning av saadana material i terapiInfo
- Publication number
- SE8901342L SE8901342L SE8901342A SE8901342A SE8901342L SE 8901342 L SE8901342 L SE 8901342L SE 8901342 A SE8901342 A SE 8901342A SE 8901342 A SE8901342 A SE 8901342A SE 8901342 L SE8901342 L SE 8901342L
- Authority
- SE
- Sweden
- Prior art keywords
- materials
- inhs
- biological materials
- therapy
- procedures
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- 239000012620 biological material Substances 0.000 title 2
- 239000000463 material Substances 0.000 title 1
- 102000000589 Interleukin-1 Human genes 0.000 abstract 6
- 108010002352 Interleukin-1 Proteins 0.000 abstract 6
- 239000003112 inhibitor Substances 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000001506 immunosuppresive effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000002700 urine Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8963287A | 1987-08-26 | 1987-08-26 | |
| PCT/US1988/002819 WO1989001946A1 (en) | 1987-08-26 | 1988-08-17 | Biological materials, processes for producing biological materials and for using such materials in therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE8901342D0 SE8901342D0 (sv) | 1989-04-13 |
| SE8901342L true SE8901342L (sv) | 1989-04-13 |
Family
ID=22218720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8901342A SE8901342L (sv) | 1987-08-26 | 1989-04-13 | Biologiska material, foerfaranden foer framstaellning av biologiska material samt foer anvaendning av saadana material i terapi |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0341273B1 (de) |
| JP (2) | JP3014099B2 (de) |
| KR (2) | KR0138919B1 (de) |
| AT (1) | ATE147408T1 (de) |
| AU (1) | AU633471B2 (de) |
| BE (1) | BE1002375A3 (de) |
| CA (1) | CA1341026C (de) |
| DE (1) | DE3855747T2 (de) |
| DK (1) | DK175837B1 (de) |
| ES (3) | ES2015348A6 (de) |
| FR (1) | FR2621821A1 (de) |
| GB (1) | GB2220662A (de) |
| HK (1) | HK1007748A1 (de) |
| IL (1) | IL87543A0 (de) |
| IT (1) | IT1226855B (de) |
| NL (1) | NL8820676A (de) |
| NZ (1) | NZ225940A (de) |
| SE (1) | SE8901342L (de) |
| WO (1) | WO1989001946A1 (de) |
| ZA (1) | ZA886251B (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6159460A (en) * | 1988-05-27 | 2000-12-12 | Amgen Inc. | Method for treating interleukin-1 mediated diseases |
| US6858409B1 (en) | 1988-05-27 | 2005-02-22 | Amgen Inc. | Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors |
| US5075222A (en) * | 1988-05-27 | 1991-12-24 | Synergen, Inc. | Interleukin-1 inhibitors |
| HU9803037D0 (en) * | 1988-05-27 | 1999-11-29 | Synergen Inc | Interleukin-1 inhibitors |
| KR0148009B1 (ko) * | 1988-05-27 | 1998-08-01 | 그래고리 비. 아보트 | 인터루킨-1 억제제 |
| HUT64582A (en) * | 1989-11-29 | 1994-01-28 | Synergen Inc | Method for producing recombinant human interleukin-1 inhibitor |
| US5714140A (en) * | 1989-12-13 | 1998-02-03 | Otsuka Pharmaceutical Co., Ltd. | Method for inhibiting the production of bioactive IL-1 by administering M-CSF |
| US6552170B1 (en) | 1990-04-06 | 2003-04-22 | Amgen Inc. | PEGylation reagents and compounds formed therewith |
| AU7683391A (en) * | 1990-04-27 | 1991-11-27 | Upjohn Company, The | Modified interleukin-1 inhibitors |
| EP0534978B1 (de) * | 1990-05-01 | 1999-03-24 | Chiron Corporation | Interleukin-i antagonist und seine verwendung |
| EP0850061A1 (de) * | 1995-09-13 | 1998-07-01 | Takeda Chemical Industries, Ltd. | Immunosuppressivum |
| US6294170B1 (en) | 1997-08-08 | 2001-09-25 | Amgen Inc. | Composition and method for treating inflammatory diseases |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4992367A (en) * | 1986-05-12 | 1991-02-12 | Hoffmann-La Roche Inc. | Enhanced expression of human interleukin-2 in mammalian cells |
-
1988
- 1988-08-17 JP JP63507716A patent/JP3014099B2/ja not_active Expired - Lifetime
- 1988-08-17 AT AT88908512T patent/ATE147408T1/de not_active IP Right Cessation
- 1988-08-17 DE DE3855747T patent/DE3855747T2/de not_active Expired - Lifetime
- 1988-08-17 KR KR1019970705000A patent/KR0138919B1/ko not_active Expired - Lifetime
- 1988-08-17 NL NL8820676A patent/NL8820676A/nl not_active Application Discontinuation
- 1988-08-17 EP EP88908512A patent/EP0341273B1/de not_active Expired - Lifetime
- 1988-08-17 HK HK98107034A patent/HK1007748A1/en not_active IP Right Cessation
- 1988-08-17 AU AU24272/88A patent/AU633471B2/en not_active Expired
- 1988-08-17 KR KR1019890700740A patent/KR0138654B1/ko not_active Expired - Lifetime
- 1988-08-17 WO PCT/US1988/002819 patent/WO1989001946A1/en not_active Ceased
- 1988-08-17 GB GB8912533A patent/GB2220662A/en not_active Withdrawn
- 1988-08-23 IL IL87543A patent/IL87543A0/xx not_active IP Right Cessation
- 1988-08-23 ZA ZA886251A patent/ZA886251B/xx unknown
- 1988-08-25 ES ES8802636A patent/ES2015348A6/es not_active Expired - Fee Related
- 1988-08-25 CA CA000575640A patent/CA1341026C/en not_active Expired - Lifetime
- 1988-08-25 IT IT8821743A patent/IT1226855B/it active
- 1988-08-26 BE BE8800975A patent/BE1002375A3/fr not_active IP Right Cessation
- 1988-08-26 FR FR8811256A patent/FR2621821A1/fr not_active Withdrawn
- 1988-08-26 NZ NZ225940A patent/NZ225940A/en unknown
-
1989
- 1989-04-13 SE SE8901342A patent/SE8901342L/ not_active Application Discontinuation
- 1989-04-26 DK DK198902031A patent/DK175837B1/da not_active IP Right Cessation
- 1989-09-16 ES ES8903149A patent/ES2017274A6/es not_active Expired - Fee Related
- 1989-09-16 ES ES8903150A patent/ES2017275A6/es not_active Expired - Fee Related
-
1998
- 1998-05-20 JP JP15671698A patent/JP3217752B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE113295T1 (de) | Tumornekrosefaktor, verfahren zu seiner herstellung, denselben enthaltende zusammensetzungen, dafür kodierende dns und diese dns verwendendes testverfahren. | |
| DK0398327T4 (da) | Tumornekrosefaktor-bindende protein, dets oprensning og antistoffer dertil | |
| MY101852A (en) | Tumor necrosis factor, methods for its preparation, containing it, dna encoding it and assay method using such dna. | |
| BR9408025A (pt) | Compostos de peptidila e seu uso terapêutico como inibidores de metaloproteinases | |
| ATE169337T1 (de) | Rekombinante expressionsvektoren und reinigungsverfahren für dns-polymerase aus thermus thermophilus | |
| SE8901342D0 (sv) | Biological materials, processes for producing biological materials and for using such materials in therapy | |
| KR100222146B1 (en) | Random bio-oligomer library, a method of systhesis thereof and a method of use thereof | |
| ATE88500T1 (de) | Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel. | |
| EA200001124A1 (ru) | Способ генной терапии | |
| DE3584775D1 (de) | Zusammensetzung zur behandlung von an haemophilia-a-inhibitor leidenden kranken. | |
| Naldini et al. | Inhibition of interleukin‐12 expression by α‐thrombin in human peripheral blood mononuclear cells: a potential mechanism for modulating Th1/Th2 responses | |
| RU94043698A (ru) | СПОСОБ ПОЛУЧЕНИЯ ФЕРМЕНТА ДЕСТАБИЛАЗЫ, ОБЛАДАЮЩЕГО ФИБРИНОЛИТИЧЕСКОЙ, ТРОМБОЛИТИЧЕСКОЙ, ЭНДО- И ЭКЗО- Е( -glu)-Lys-ИЗОПЕПТИДАЗНОЙ И АМИДОЛИТИЧЕСКОЙ АКТИВНОСТЬЮ | |
| SG128403A1 (en) | Tnf-receptors, tnf binding proteins and dnas coding for them | |
| DE69222636D1 (de) | Anti-hiv protein, tap-29, aus trichosanthes, seine kodierende dna und therapeutischen anwendungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 8901342-9 Effective date: 19901007 |